Transfer of value disclosure describes the funding received from non-NHS organisations to support programmes of work that aim to improve the health and care system in the North West Coast.


This includes:

Grants/donations - when the aims and objectives are set by the NHS organisation, and the industry body provides only resource (which could be for example financial resource, human resource or other resource).

Joint Working and Collaborative working - occurs when the aims and objectives are developed jointly and shared, with both parties contributing both resources and thinking.

Both of the types of arrangement are accepted forms of relationships with industry. It also applies to donations by non-profit making or charitable organisations. Any transfer of value not defined as donations and grants, joint working or collaborative working are out of scope of this disclosure guidance and not subject to disclosure.

Guidance for this Disclosure of Transfer of Value has been informed by the Association of British HealthTech Industries (ABHI) code of ethical business conduct and Association of the British Pharmaceutical Industry (ABPI) code of practice . It is intended to apply to all industry interactions whether they involve ABPI / ABHI members or not.

The working principles of transfer of value disclosure are:

  • Patients’ needs first
  • Improving value from public money
  • Alignment with local and national priorities
  • A balanced, whole systems approach to healthcare
  • Openness and transparency





Organisations Involved

Start Date

End Date

Monetary Value

Reason for Benefit

Health Innovation North West Coast Owner

Health Innovation North West Coast

Roche Diagnostics Ltd and Roche Products Ltd


Health Innovation North East and North Cumbria

Health Innovation Yorkshire & Humber

October 2021

June 2023

Collaborative Agreement £116,000 up to March 2022. Budget for 2022/23 to be confirmed.

Benefitting Healthier South Wirral PCN, Calderdale GP surgery, Newcastle Gateshead CCG, Cumbria Health on Call, North East Pharmacies x 2, and Durham Dales Health Federation (tbc).

Health Innovation North West Coast

Daiichi-Sankyo (DS)

March 2022

March 2023

Joint Working Arrangement £92,074.90.

DS financial contribution - £40,189.90.

Improvements in the identification and management of AF and make best use of technology and innovation.

Health Innovation North West Coast 

Amgen Ltd.

January 2020

September 2022

(Delays of 9 months due to COVID, end date subject to discussion)

Joint Working Arrangement £560,000.

Amgen financial contribution - £310,000.

This work is to fund the development and implementation of the lipids pathway and look at 4 different approaches in PCNs.

Health Innovation North West Coast 

Sanofi Ltd.

April 2022

December 2022

Joint Working Arrangement £20,983

Sanofi financial contribution - £10,476.

This work is to fund the development and implementation of a pathway for finding FH patients in primary care and managing them in partnership with hospital specialists.


All the latest from the Health Innovation North West Coast...